Compatibility of paroxetine hydrochloride and GW597599B: A physico-chemical approach

Journal of Thermal Analysis and Calorimetry

Volumn 108, Issue 1, 2012, Pages 381-388

  Bruni, Giovanna ^a   Sartor, Franco ^b   Berbenni, Vittorio ^a   Milanese, Chiara ^a   Maietta, Mariarosa ^a   Franchi, Dionigio ^c   Marini, Amedeo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Aptuit Inc   (United States)

^c GSK   (Italy)

Author keywords

Hydrate; Interaction; Physico chemical properties; Pseudo polymorphism; Solid state; Thermal analysis

Indexed keywords

CALORIMETRIC CURVES; EUTECTIC FORMATION; EXPERIMENTAL CONDITIONS; INTERACTION; PAROXETINE; PAROXETINE HYDROCHLORIDE; PHYSICAL MIXTURES; PHYSICO-CHEMICAL PROPERTIES; PHYSICO-CHEMICALS; PSEUDOPOLYMORPHISM; THERMAL CHARACTERIZATION; THERMAL RESPONSE; THERMODYNAMIC AND STRUCTURAL PROPERTIES;

CHEMICAL PROPERTIES; HYDRATES; THERMOANALYSIS;

DRUG INTERACTIONS;

EID: 84858081227     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-011-2051-2     Document Type: Article

References (23)

1. AJ Goudie W Dubicki M Leathley 1998 Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents J Pharm Pharmacol 40 3 192 196 10.1111/j.2042-7158.1988.tb05217.x
2. MB Keller 2003 Paroxetine treatment of major depressive disorder Psycopharmacol Bull. 37 42 52
3. S Saxena AL Brody ML Ho S Alborzian KM Maidment N Zohrabi MK Ho SC Huang HM Wu LR Baxter 2002 Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression Arch Gen Psychiatry 59 3 250 261 10.1001/archpsyc.59.3.250 1:CAS:528:DC%2BD38XisVWluro%3D (Pubitemid 34212502)
4. DJ Stein M Versiani T Hair R Kumar 2002 Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study Arch Gen Psichiatry. 59 12 1111 1118 10.1001/archpsyc.59.12.1111 1:CAS:528: DC%2BD38XpslejsL8%3D (Pubitemid 35424021)
5. SR Vippagunta HG Brittain DJW Grant 2001 Crystalline solids Adv Durg Deliv Rev. 48 3 26 10.1016/S0169-409X(01)00097-7 1:CAS:528:DC%2BD3MXivFejsrs%3D (Pubitemid 32452290)
6. D Giron C Goldbronn M Mutz S Pfeffer P Piechon 2002 Solid state characterizations of pharmaceutical hydrates J Therm Anal Calorim 68 453 465 10.1023/A:1016031517430 1:CAS:528:DC%2BD38XkvFegsrw%3D (Pubitemid 34614446)
7. RK Khankari DJW Grant 1995 Pharmaceutical hydrates Thermochim Acta. 248 61 79 10.1016/0040-6031(94)01952-D 1:CAS:528:DyaK2MXivVOrtrw%3D
8. D Giron 2001 Investigations of polymorphism and pseudo-polymorphism in pharmaceuticals by combined thermoanalytical techniques J Therm Anal Calorim 64 37 60 10.1023/A:1011572610005 1:CAS:528:DC%2BD3MXktFyjs7c%3D (Pubitemid 32512102)
9. A Marini V Berbenni G Bruni P Cofrancesco F Giordano M Villa 2003 Physico-chemical characterization of drugs and drug forms in the solid state Curr Med Chem Anti Infect Agents 2 303 321 10.2174/1568012033483024 1:CAS:528:DC%2BD3sXptVGmsrw%3D
10. A Marini V Berbenni G Bruni C Margheritis A Orlandi 2001 Physicochemical study of the solid forms of a new drug J Pharm Sci 90 2131 2140 10.1002/jps.1164 1:CAS:528:DC%2BD3MXpt1Clsbc%3D (Pubitemid 33144458)
11. A Marini V Berbenni G Bruni A Maggioni P Cofrancesco C Sinistri A Orlandi M Villa 2003 Solid state characterization of a novel chemotherapeutic drug J Pharm Sci 92 577 584 10.1002/jps.10315 1:CAS:528:DC%2BD3sXitVWqu7s%3D (Pubitemid 36258972)
12. A Marini V Berbenni G Bruni P Cofrancesco C Margheritis A Orlandi M Villa 2004 Hydration, stability and phase transformations of a new antitumor drug J Pharm Sci 93 2222 2231 10.1002/jps.20128 1:CAS:528:DC%2BD2cXnsVeguro%3D (Pubitemid 39129620)
13. G Bruni V Berbenni C Milanese A Girella A Cardini S Lanfranconi A Marini 2010 New modifications of nateglinide J Pharm Biomed Anal 51 1054 1059 10.1016/j.jpba.2009.11.019 1:CAS:528:DC%2BC3cXps1Gk
14. JA Ibers 1999 Paroxetine hydrochloride hemihydrate Acta Cryst. C55 432 434 1:CAS:528:DyaK1MXis1yqs7c%3D (Pubitemid 129621901)
15. IR Lynch PC Buxton JM Roe 1988 Infrared spectroscopic studies on the solid state forms of paroxetine hydrochloride Anal Proc 25 305 306 1:CAS:528:DyaL1cXlvFOjsb0%3D
16. PC Buxton IR Lynch M Roe 1988 Solid-state forms of paroxetine hydrochloride Int J Pharm. 42 43 10.1016/0378-5173(88)90169-X
17. Olive MF, Whistler J. Antagonizing NK1 receptors inhibits consumption of substances of abuse, EPO Patent EP1556054 2003.
18. F Chenu BP Guiard M Bourin AM Gardier 2006 Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test Behav Brain Res 172 256 263 10.1016/j.bbr.2006.05.011 1:CAS:528:DC%2BD28Xot1Wrsr4%3D (Pubitemid 44164519)
19. G Bruni C Milanese V Berbenni F Sartor M Villa A Marini 2010 Cristalline and amourphous phases of a new drug J Therm Anal Calorim 102 297 303 10.1007/s10973-009-0614-2 1:CAS:528:DC%2BC3cXhtFartLzJ
20. G Bruni L Amici V Berbenni A Marini A Orlandi 2002 Drug-excipient compatibility studies: search of interaction indicators J Therm Anal Calorim 68 561 573 10.1023/A:1016052121973 1:CAS:528:DC%2BD38XkvFegsL8%3D (Pubitemid 34614455)
21. A Marini V Berbenni S Moioli G Bruni P Cofrancesco C Margheritis M Villa 2003 Drug-excipient compatibility studies by physico-chemical techniques: the case of indomethacin J Therm Anal Calorim 73 529 545 10.1023/A:1025426012578 1:CAS:528:DC%2BD3sXnslGisbo%3D
22. A Marini V Berbenni M Pegoretti G Bruni P Cofrancesco C Sinistri M Villa 2003 Drug-excipient compatibility studies by physico-chemical techniques: the case of atenolol J Therm Anal Calorim 73 547 561 10.1023/A:1025478129417 1:CAS:528:DC%2BD3sXnslGisbs%3D
23. G Bruni V Berbenni C Milanese A Girella A Marini 2010 Drug-excipient compatibility studies in binary and ternary mixtures by physico-chemical techniques J Therm Anal Calorim 102 193 201 10.1007/s10973-009-0382-z 1:CAS:528:DC%2BC3cXhtFartL%2FM